Latest News

Tuesday, May 05, 2015 | Clinical Trials, Eleven Biotherapeutics

Eleven Biotherapeutics Presents Data on EBI-031 for the Treatment of Diabetic Macular Edema at ARVO

Eleven Biotherapeutics announced the presentation of data for EBI-031, its novel, protein therapeutic IL-6 inhibitor in preclinical development for diabetic macular edema, at the Association for Resea…

Read the full story

Tuesday, May 05, 2015 | Acquisitions/Mergers, OPKO Health

OPKO Health Acquires EirGen Pharma

OPKO Health has announced the acquisition of EirGen Pharma, a specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceut…

Read the full story

Tuesday, May 05, 2015 | Clinical Trials, Transcend Medical

Transcend Medical Announces Intent to File Premarket Approval Application With FDA for the CyPass Glaucoma Micro-Stent

Transcend Medical announced its intent to file a premarket approval (PMA) application with the FDA for the CyPass Micro-Stent, a novel minimally invasive glaucoma surgical (MIGS) implant, according to…

Read the full story

Tuesday, May 05, 2015 | Partnerships, Envision

Envision to Partner with Gimbal, the Leaders in Proximity-Based Mobile Engagement

Envision announced that it has formed a new partnership with California-based technology company Gimbal, a leading provider of location and proximity-based mobile engagement. This joint partnership wi…

Read the full story

Tuesday, May 05, 2015 | Cataract Surgery, Medical Studies

Intraocular Lenses Growing in Popularity

New developments in intraocular lenses have led to the expansion of the number of patients who could benefit from them, experts report. Only 0.2% of Americans with presbyopia have intraocular lenses. …

Read the full story

Tuesday, May 05, 2015 | Grants/Awards

Johns Hopkins, Minnesota Researchers Win Prestigious Helen Keller Prize for Vision Research Award Honors Pioneers in Low-Vision Research

Gordon E. Legge of the University of Minnesota and Robert Massof of the Johns Hopkins Wilmer Eye Institute will receive today the prestigious 2015 Helen Keller Prize for Vision Research. The award is …

Read the full story

Tuesday, May 05, 2015 | Medical Studies

Study: Eye Banks are Able to Successfully Prepare and Transport Fully Peeled DMEK Tissue

Eye banks are capable of preparing fully peeled corneal tissue and transporting them to surgical centers for use in Descemet’s membrane endothelial keratoplasty (DMEK), according to a new study …

Read the full story

Monday, May 04, 2015 | Miscellaneous

American Academy of Ophthalmology Committed to Supporting Eye Care in Nepal After Earthquake

In response to the devastating earthquake that struck Nepal on April 25, the American Academy of Ophthalmology has established the Nepal Eye Care Relief Fund. This fund will support rebuilding efforts…

Read the full story

Monday, May 04, 2015 | Clinical Trials, Eyegate Pharmaceuticals

EyeGate Pharma Receives Positive Guidance From FDA on NDA Filing Requirements of EGP-437 for the Treatment of Anterior Uveitis

Eyegate Pharmaceuticals announced receipt of comments from the FDA in response to questions submitted by the company ahead of a Type B meeting scheduled for May 5, 2015, according to a company news re…

Read the full story

Monday, May 04, 2015 | Partnerships, Clearside Biomedical , Santen

Clearside Biomedical and Santen Announce Research Collaboration in Glaucoma

Clearside Biomedical and Santen announced the expansion of their research collaboration to include the field of glaucoma. The two companies have been working together since January 2013 to develop dru…

Read the full story

Monday, May 04, 2015 | Partnerships, Shire

Shire and Foundation Fighting Blindness Announce New Research Agreement for Rare Eye Disease First Appearing in Childhood or Adolescence

Shire and the Foundation Fighting Blindness announced a new agreement focused on furthering research for a novel treatment for autosomal dominant retinitis pigmentosa (adRP), a rare genetic disease th…

Read the full story

Monday, May 04, 2015 | Clinical Trials, Allegro Ophthalmics

Allegro Ophthalmics Begins Phase 2 Clinical Study of Luminate for Non-Proliferative Diabetic Retinopathy

Allegro Ophthalmics announced that it has begun enrolling patients in a phase 2 clinical trial that will evaluate the safety and efficacy of Allegro’s first-in-class integrin peptide therapy can…

Read the full story

Monday, May 04, 2015 | Medical Studies

Study: Endothelial Cell Density is Not Significantly Different Between Diabetic and Non-Diabetic Corneas

A new study from the Lions Eye Institute for Transplant & Research (LEITR) and Montefiore Medical Center at the Albert Einstein College of Medicine finds that there is no statistically significant…

Read the full story

Monday, May 04, 2015 | Management/Leadership, Acucela

Acucela Shareholders Elect New Board Members

Acucela announced that shareholders have elected four new members to the company’s board of directors at a special meeting of the company’s shareholders, according to a company news releas…

Read the full story

Monday, May 04, 2015 | Conferences, Bausch+Lomb

Bausch + Lomb Presents New Scientific and Clinical Research During ARVO

Bausch + Lomb will present numerous scientific posters during the Association for Research in Vision and Ophthalmology (ARVO) annual meeting in Denver, May 3-7, according to a company news release. Th…

Read the full story
Load More
 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $10.61  -2.84% 
 Akorn, Inc. $40.00  -5.24% 
 Alimera Sciences, Inc. $4.28  0.00% 
 Allergan, Inc. $240.22  0.00% 
 Avalanche $29.44  -5.03% 
 Bayer $141.86  -2.31% 
 Can-Fite Biopharma $2.41  -9.06% 
 Carl Zeiss Meditec $22.75  -0.65% 
 Cooper Companies, Inc. $177.44  -0.92% 
 Escalon Medical Corp. $1.49  1.36% 
 Essilor International $121.00  0.00% 
 Imprimis Pharmaceuticals, Inc. $7.87  -1.69% 
 InSite Vision, Inc. $0.15  0.00% 
 IRIDEX Corporation $9.72  -0.41% 
 Johnson & Johnson $99.50  -0.85% 
 LCA-Vision Inc. $5.37  0.00% 
 Luxottica Group, S.p.A. $65.00  -4.21% 
 Merck & Company, Inc. $60.49  -0.25% 
 NicOx $1.88  -1.05% 
 NovaBay Pharmaceuticals, Inc. $0.62  -2.44% 
 Novartis AG Common Stock $102.17  -1.39% 
 Ocular Therapeutix $21.49  -3.63% 
 Ophthotech Corporation $45.82  -3.80% 
 Quantel $2.95  -0.67% 
 Regeneron $465.50  -1.83% 
 Roche $35.93  -0.33% 
 STAAR Surgical Company $8.98  0.34% 
 TearLab Corporation $2.59  1.97% 
 Thrombogenics $6.35  0.00% 
 Topcon Corporation $26.20  0.00% 
 Valeant Pharmaceuticals $219.24  -1.62% 
 Xoma $3.15  -3.08%